Direxion Daily Financial Bull 3X Shares ETF
FAS
Ultra Financials Proshares
UYG
Spdr S&P Bank Etf
KBE
4
SPDR S&P Metals & Mining ETF
XME
5
SPDR S&P Retail ETF
XRT
US Stock MarketDetailed Quotes
GeneDx Holdings (WGS)
- 136.870
- -4.850-3.42%
Trading Dec 17 15:41 ET
3.96BMarket Cap1244.27P/E (TTM)
144.570High133.900Low380.20KVolume143.360Open141.720Prev Close52.25MTurnover1.84%Turnover RatioLossP/E (Static)28.90MShares170.87052wk High13.54P/B2.83BFloat Cap55.17052wk Low--Dividend TTM20.70MShs Float896.940Historical High--Div Yield TTM7.53%Range %1.160Historical Low137.425Avg Price1Lot Size
WGS Stock Chart
Real-Time
- 5D
- Daily
- Weekly
- Monthly
- 1Q
- 1Y
WGS Orderflow
Unit: --
WGS Orderflow Trend
IntradayDayWeekMonth
No Data
GeneDx Holdings (WGS) News
Express News | GeneDx Holdings Corp : Jefferies Raises Target Price to $180 From $150
GeneDx Holdings Is Maintained at Equal-Weight by Wells Fargo
GeneDx's GUARDIAN Study Honored By JAMA For Demonstrating Genomic Newborn Screening Can Detect Serious Childhood Conditions Missed By Traditional Methods
Wells Fargo Maintains GeneDx Holdings(WGS.US) With Hold Rating, Raises Target Price to $155
Express News | GeneDx Holdings Corp. : Wells Fargo Raises Target Price to $155 From $140
JAMA (Journal of the American Medical Association) Recognizes GUARDIAN Newborn Genomic Screening Study Among Its Research of the Year
GeneDx Holdings (WGS) Stock Forum
Here's every move Cathie Wood and Ark Invest made in the stock market today 12/4
2
7
1
Expand 1
Morning Movers
Gapping Up
$Sarepta Therapeutics (SRPT.US)$ jumped 40% after the FDA recommended lifting a voluntary pause on shipments of its Duchenne muscular dystrophy treatment, Elevidys.
$GeneDx Holdings (WGS.US)$ rose 27% after swinging to Q2 adjusted earnings and raising its FY2025 revenue guidance on stronger revenue.
$Chart Industries (GTLS.US)$ advanced 16% following stronger-than-expected Q2 earnings and news of a $210-p...
Gapping Up
$Sarepta Therapeutics (SRPT.US)$ jumped 40% after the FDA recommended lifting a voluntary pause on shipments of its Duchenne muscular dystrophy treatment, Elevidys.
$GeneDx Holdings (WGS.US)$ rose 27% after swinging to Q2 adjusted earnings and raising its FY2025 revenue guidance on stronger revenue.
$Chart Industries (GTLS.US)$ advanced 16% following stronger-than-expected Q2 earnings and news of a $210-p...
Expand 11
2
Read more
Market Insights
Hot Topics Hot Topics
Surf the ETF wave: Master the market with wisdom & ease!
As the financial landscape evolves, ETFs have emerged as a versatile tool for investors seeking to grow wealth, diversify portfolios, and st
102362254
Sep 4, 2024 16:25
Sharing my long-term ETF story
mr_cashcow
Sep 11, 2024 10:30
Low cost ETF is the way to go! September P/L challenge #6 (200words count entry)
Aspiring : I am not sure why prople are still folloeing Cathy Wood trades. Her ETF has the 3rd worst performsnce for the last years that has eipec billions from investors. She may be right in decidions but you should take it with cautios.
JohnnyWalkerBlue : she has no balls so she influenced everyone to dump their balls away when she sells. then buy back suddenly grapping back all the fallen balls at their lowest point.
Bin Li 知行合一 JohnnyWalkerBlue : Thank you for your explanation
Sheto : god bless you
Inner Yo Aspiring : $ARK Space & Defense Innovation ETF (ARKX.US)$ has performed for me and made people a lot of money. (EDIT: also, it would be respectful to the people you are comminicating to TRY to spell words.)
View more comments...